VanEck Biotech ETF (BBH) Price, Holdings, & News

ETF Overview

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

Key Stats

• Today's Range: $149.19 to $150.61
• 50-Day Range: $140.05 to $162.87
• 52-Week Range: $135.34 to $183.64
• Volume: 11,029 shs
• Average Volume: 8,877 shs
• Market Capitalization: $344.48 million
• Assets Under Management: $328.85 million
• Dividend Yield: 0.83%
• Net Expense Ratio: 0.35%
• Aggregate Rating: Moderate Buy

BBH ETF - Frequently Asked Questions

How have BBH shares performed this year?

VanEck Biotech ETF's stock was trading at $156.97 at the beginning of 2025. Since then, BBH stock has decreased by 4.1% and is now trading at $150.5780.
View the best growth stocks for 2025 here.

Who are VanEck Biotech ETF's major shareholders?

Top institutional investors of VanEck Biotech ETF include Jones Financial Companies Lllp (6.64%), Goldman Sachs Group Inc. (4.64%), Miller Investment Management LP (4.01%) and LPL Financial LLC (1.06%).

How do I buy shares of VanEck Biotech ETF?

Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of VanEck Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Meta Platforms (META), Micron Technology (MU), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Adobe (ADBE) and Johnson & Johnson (JNJ).

Fund Details

• Issuer: Van Eck
• Fund Name: VanEck Biotech ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NASDAQ
• Current Symbol: NASDAQ:BBH
• Inception Date: 12/20/2011
• Fund Manager: Hao-Hung Peter Liao, Guo Hua Jason Jin
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: MVIS US Listed Biotech 25 Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: Global
• Number of Holdings: 25

Fund Statistics

• Assets Under Management: $328.85 million
• Average Daily Volume: $12,606.50
• Discount/Premium: -0.19%

Administrator, Advisor and Custodian

• Administrator: Van Eck Associates Corporation
• Advisor: Van Eck Associates Corporation
• Custodian: State Street Bank and Trust Company
• Distributor: Van Eck Securities Corporation
• Transfer Agent: State Street Bank and Trust Company
• Trustee: N/A
• Lead Market Maker: Virtu Financial

Options

• Optionable: N/A
• Short Interest: 6,600 shs

Miscellaneous

• Outstanding Shares: 2,290,000
• Beta: 0.85
• Creation Unit: 50,000
• Creation Fee: $500.00